Beyond the Register: A 2026 UK Checklist for Reading CBD Labels and Lab Reports

Most UK CBD buyers now know to look for a Novel Foods listing. That is progress. But a register entry is a regulatory signpost, not a certificate of quality, potency or clinical benefit. In 2026, the more useful question is not simply whether a product appears on the Food Standards Agency’s novel foods register, but what the entry actually covers and whether the batch in your hand can be traced to a documented specification.

What the register is for

UK novel food rules apply to CBD extracts and other cannabinoid preparations that were not consumed to a significant degree before May 1997. The Food Standards Agency maintains a register of novel foods, and CBD products may appear on it in connection with an application or authorisation process. For a shopper, this can help separate products that have been brought into a visible regulatory route from those with no obvious route at all.

That is a meaningful distinction. It is not, however, a clinical endorsement. A listing does not mean the product has been proven to treat pain, anxiety or sleep problems. It does not mean every batch has been tested to the same standard. And it does not replace the need to read the label, check the batch and examine the laboratory certificate.

What a listing cannot tell you

A Novel Foods entry is not product-specific proof of efficacy. It is not a medicine licence. It is not a guarantee that the cannabinoid content on the label matches the bottle. It is not evidence that the product is suitable for everyone, including people who are pregnant, breastfeeding, taking prescription medicines or living with liver or kidney problems.

Regulatory status and evidence of effectiveness are separate axes. A product can sit within a regulatory process and still have little or no published clinical evidence behind the specific finished product. Equally, a brand may cite interesting ingredient research while selling an oil whose dose, formulation or absorption profile has never been studied. UK readers should hold both ideas at once rather than treating one as a proxy for the other.

A label-and-lab checklist

1. Trace the product to a batch

A serious label should include a batch number or lot number. The certificate of analysis, often called a COA, should match that batch. If the brand shows only a generic report with no batch link, you cannot know whether the document refers to the bottle you are considering.

2. Read the certificate of analysis properly

Look for the date of analysis, the sample identity and the laboratory’s name. Check whether the sample was the finished product or a raw ingredient. A raw CBD isolate report is not the same as a report on a formulated oil containing carrier oils, flavourings and other ingredients. The COA should state the methods used and show results against defined limits.

3. Check the laboratory

In the UK, a useful marker is accreditation to ISO/IEC 17025 by UKAS or an equivalent national accreditation body. Accreditation is not a guarantee that a product is effective, but it does indicate that the laboratory has been assessed for competence in specific tests. A PDF with a logo and no laboratory identity is difficult to verify.

4. Look at the cannabinoid profile and THC

A credible report should show more than total CBD. It should distinguish CBD from other cannabinoids where relevant and report THC. For a UK buyer, a report that omits THC is incomplete. The numbers should also be consistent with the label’s declared strength after allowing for reasonable analytical variation.

5. Check contaminants

CBD oils are plant-derived products, so testing should address pesticides, heavy metals, residual solvents and microbial contamination. The exact panel depends on the product and its extraction route, but the principle is simple: the report should show what was tested and the limits applied. ‘Lab tested’ without a readable COA is a slogan, not evidence.

6. Check dose and serving size

The label should make clear how much CBD is in each drop, spray or capsule and how many servings the bottle contains. A large total milligram figure can look impressive while the per-serving dose is small. Readers should also be cautious about products that encourage very high daily intakes without explaining why.

7. Test the claims

Regulatory status does not license disease claims. If a product page says a CBD oil treats anxiety, cures insomnia or reduces inflammation, the register entry does not make that claim lawful or proven. UK advertising rules require claims to be evidence-based and not misleading. A brand that mixes a Novel Foods reference with medical promises is asking you to confuse compliance paperwork with clinical proof.

Questions worth asking a brand

Which exact register entry applies to this product? Can you send the batch-specific COA? Which laboratory produced it, and is that laboratory accredited for the tests shown? Was the finished product tested or only the raw material? What is the THC result for this batch? How do you handle batch-to-batch variation? And which published studies, if any, relate to this finished product at this dose?

A brand that answers clearly is not automatically trustworthy, but a brand that cannot answer at all is giving you useful information. Vague replies about ‘industry standards’ or ‘lab testing’ are not a substitute for documents.

Red flags in 2026

Be wary of ‘Novel Foods approved’ when the evidence is only a listing. Be wary of ‘clinically proven’ without a citation to a peer-reviewed study on the relevant product. Treat ‘pharmacist approved’ as ambiguous unless the pharmacist is named and the scope of approval is explained. Be cautious about ‘full spectrum’ claims that come without a THC result, and about trust badges that cannot be clicked through to a verifiable source.

The bottom line

The Novel Foods register is worth checking, but it should be the beginning of your audit, not the end. A cautious UK buyer should move from the register to the batch, from the batch to the COA, and from the COA to the claims. That sequence will not tell you whether CBD will work for you, but it will help you judge whether a brand is being transparent about what it sells.

This article is educational and is not medical advice. If you are considering CBD alongside prescription medicines or have a health condition, speak to a qualified healthcare professional.